NCT03330327View on ClinicalTrials.gov

Molar Potency Study of HM12470 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

August 17, 2017

Study Completion Date

August 17, 2017

Conditions
Healthy Subjects
Interventions
BIOLOGICAL

HM12470

HM12470 is a long-acting insulin analogue

Trial Locations (1)

91911

Hanmi Investigative Site, Chula Vista

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT03330327 - Molar Potency Study of HM12470 in Healthy Subjects | Biotech Hunter | Biotech Hunter